Infant and juvenile rhesus macaques exhibit many sexually dimorphic behaviors, including rough and tumble play, mounting, and time spent with nonmother females. This study investigated sex differences in infant rhesus monkey separation-rejection vocalizations (SRVs), and the effects of altering the prenatal hormone environment on these differences. Pregnant females received exogenous androgen (testosterone enanthate), an androgen antagonist (flutamide), or vehicle injections for 30 or 35 days during the second (early) or third (late) trimester of pregnancy. Control females used a greater percentage of coos and arched screams than did control males. In contrast, males used a greater percentage of geckers and noisy screams than did females. Females also had longer SRV bouts, used more calls, and used more types of vocalizations than did males. Mothers were more likely to respond to the SRVs of male infants than to the SRVs of female infants. Prenatal flutamide treatment early in gestation reduced the likelihood that mothers would respond to their male offspring, but prenatal androgen treatment had no effect on response rates of mothers to female offspring. Early, but not late, androgen treatment produced females who vocalized in a male-typical manner. Similarly, early flutamide treatment produced males who displayed more female-typical SRVs. Late flutamide treatments of females produced as much masculinization of SRVs as did early androgen treatment in females. These results demonstrate sex differences in highly emotional vocalizations in infant rhesus macaques and provide evidence that the timing and form of prenatal hormonal exposure influence such vocalizations.
Infant and juvenile rhesus monkeys exhibit sexually dimorphic behavior that may reflect the differing life histories of males and females and that is strongly influenced by differences in the prenatal hormone environment (Wallen, 1996) . Differences in male and female life histories may reflect the fact that, in rhesus macaques, as well other cercopithecines, social structure is based upon stable, linearly ranked matrilines with strong bonds among female kin, coupled with a male-biased postpubertal dispersal (Melnick and Pearl, 1987) . Since females usually have relatives in the social group, they are more likely to engage in affiliative behaviors and use social vocalizations than are their male counterparts (Cheney and Seyfarth, 1990) . For example, female infants spend more time with their mothers and their mother's allies than do male infants (Berman, 1982; Lovejoy and Wallen, 1988) , whereas juvenile males engage in more mounting and rough play than do females (Lovejoy and Wallen, 1988; Wallen, Maestripieri, and Mann, 1995) . This study investigated sex differences in infant vocalizations and how prenatal androgen manipulations affected these differences.
Several sex differences in juvenile behavior appear to be related to the prenatal androgen environment of the developing fetus (Wallen, 1996) . Experimentally increasing prenatal androgens in females increases the expression of the male-typical juvenile sexually dimorphic behaviors of mounting and rough and tumble play (Eaton, Worlein, and Glick, 1990; Goy, Bercovitch, and McBrair, 1988; Wallen, 1996) . The effects of androgen are not uniform throughout gestation, with androgen exposure influencing sexually dimorphic behavior differentially at different gestational ages (Goy et al., 1988) . For example, 25 days of androgen exposure starting on day 40 of the 168-day gestation extensively masculinized female genitalia and behav-iorally masculinized mounting, but had no effect on play behavior. In contrast, 25-day androgen treatments starting on day 110 of gestation produced no apparent genital masculinization, but masculinized both mounting and play behavior (Goy et al., 1988) . These results led Goy et al. to conclude that the behavioral effects of prenatal androgen were independent of its effects on genital masculinization and that the developing nervous system was sensitive to the organizing actions of androgens throughout a large portion of gestation. Furthermore, these findings suggest that critical periods for the development of specific sexually dimorphic behaviors occur at different times during gestation, whereas there appears to be a single critical period for genital masculinization.
Adult rhesus macaques show sex differences in vocalizations, with adult males, unlike adult females, rarely using screams to recruit aid during agonistic interactions (Bernstein and Ehardt, 1985) . Similarly, males use fewer food-associated calls than do adult females (Hauser and Marler, 1993) . However, little is known about sex differences in early vocal behavior. Erwin and Mitchell (1973) reported that, starting at 2 months of age, females use more coos than do males in response to maternal separation. Kalin and Shelton (1998) , however, found no sex differences in coo usage in older infants using a similar experimental paradigm. Juvenile males were found to scream less than females of any age class, despite the fact that they were more likely than females to be the target of aggression (Bernstein and Ehardt, 1985) . Similarly, in infant vervet monkeys, Locke and Hauser (1999) found females to be more voluble than males, independent of the type of vocalization. In addition to sex differences in volubility and call usage, sex differences in vocalizations have been found in the appropriate usage of calls. For example, in pigtail macaques, a species closely related to rhesus macaques, females become communicatively competent in the use and production of screams used in the recruitment of agonistic support at an earlier age than do males Gouzoules, 1989, 1995) . Overall, the life history pattern appears to be that females use vocalizations socially and remain highly vocal throughout life, whereas males become increasingly silent.
Although no study has investigated the effects of prenatal hormones on sex differences in vocalizations, there is evidence that structural brain differences can be related to sex differences in infant vocalizations, suggesting the possibility of prenatal hormonal influences. Newman and Bachevalier (1997) found that lesions to inferior temporal cortex (area TE) increased noisy scream calling rates in male infants during maternal separation, but did not alter noisy scream rates in females and argued that these differences stemmed from hormonally influenced differential brain development (Newman and Bachevalier, 1997) .
Infant vocalizations occur most often during periods of distress. The present study focused on vocalization bouts occurring during periods of rejection or separation from the infant's mother, which we term "separation-rejection vocalizations" (SRVs), and examined sex differences in infant SRVs and how these differences were affected by prenatal androgen manipulations. We tested both the effects of exposure to increased androgen, via treatment of the mother with exogenous testosterone, and the effect of blocking the action of endogenous androgens by administering an androgen receptor blocker, flutamide. Treatments were administered either early or late in gestation, allowing investigation of both the role of androgen and the timing of androgen exposures on infant vocalizations.
METHODS

Subjects
Subjects were derived from pregnancies in two groups of rhesus macaques housed socially in 38 ϫ 38 m outdoor enclosures with attached 3 ϫ 10 m indoor enclosures at the Yerkes Regional Primate Center Field Station in Lawrenceville, Georgia. Each group had been formed at least 20 years prior to the start of the study and consisted of approximately 100 individuals, including adult males, adult females, and their juvenile and infant offspring. The 74 subjects included all infants born in these two groups in two cohorts, across two annual breeding seasons (1996 and 1997) .
Prenatal Hormone Treatments
For each cohort, pregnant females were randomly assigned to one of 10 treatment groups. Conception dates were estimated through a combination of mating observations and ultrasound assessment of fetal growth, which allowed for the determination of conception within 3 days (Zehr, Jones, Tannenbaum, and Wallen, submitted for publication). A total of 58 infants were prenatally treated with testosterone enanthate (Sigma Corp.), flutamide (Sigma Corp.), or DMSO (vehicle control, Sigma Corp.) either early or late in gestation. Sixteen additional unmanipulated controls (7 females and 9 males) were included in the study.
Details of the treatments are published elsewhere (Herman, Jones, Mann, and Wallen, 2000) . Briefly, all treatments were administered to pregnant females via IM injections according to the following injection protocols. Flutamide (30 mg/kg dissolved in DMSO, based on weight at ultrasound) and DMSO (0.25 cc) were both administered twice per day, every day for 30 or 35 days, either from gestation days 40 to 70 (early treatment, cohort 1) or days 35 to 70 (cohort 2) or from gestation days 115 to 145 (late treatment, cohort 1) or days 110 to 145 (cohort 2). Testosterone treatments (20 mg, dissolved in oil) were administered once per week for 4 weeks, and DMSO was administered the other 6 days, so that all treatment females were comparably manipulated during pregnancy. Table 1 presents the 10 treatment groups and 2 unmanipulated groups, with the number of subjects in each group by cohort and sex.
Observations/Data Collection
Vocalizations were recorded throughout the first 8 months of life. Observations and recordings were made from ground level immediately outside the outdoor housing area, beginning within the first week of life. All individuals were identifiable to the primary observer (MT), and all subjects and their mothers were marked with a two-letter code, in aniline dye on the hair of their back, to aid in identification. Data were collected in 2-h sessions, approximately 3 days per week, during periods in which the animals are most likely to be active (from 0700 to 1100 h and from 1500 to 2000 h). During observations, animals were locked out of the indoor area, so that all animals were visible to the observers. An "all-occurrences" technique (Altmann, 1974 ) was used to collect both vocalizations and contextual data. One observer tape-recorded the calls and the primary observer (MT) recorded relevant contextual information, including the identity of the caller, the distance between the mother and the infant (using three categories-contact, proximity, and outside of proximity), and all behaviors occurring during, at the end of, and after the vocalizations, as well as any preceding behaviors when known. Vocalizations were recorded using a Sony TCM-5000 tape recorder and a Sennheiser directional microphone (Model MKH 816). Only SRV bouts, vocalizations in response to maternal rejection or separation, from the first 8 months of life, are considered in the present analysis.
Observers were not blind to the sex of the subjects, as genitalia were not masked in any way. With the exception of some early flutamide-treated males, prenatal treatment was not discernible from genital anatomy (Herman et al., 2000) . To minimize potential observer bias, data were collected and calls were analyzed by the subject's two-letter code only. Only after the data had been reduced were subjects assigned to their appropriate sex and treatment groups.
Data Analysis
Mother behavior and infant behavior were noted for each SRV bout. Since all SRV bouts involved distance between the mother and the infant, either within proximity (within arm's reach) or outside of proximity, bouts were characterized by whether or not contact was initiated by the mother or infant or if contact was not established at the end of the vocal bout. Infant behavior was either characterized as "approach mother" if the infant actively approached the mother at the end of the SRV or as "no approach to mother" if the infant did not seek contact with the mother and simply stopped vocalizing. The mother's behavior was classified as "responsive" if she retrieved or approached the infant at the end of a SRV or "ignoring" if the mother made no attempt to contact the infant. SRVs were digitized and analyzed using RTS (Real Time Spectrum Analyzer, Engineering Design, Belmont, MA), with a sampling rate of 48 kHz. Individual calls were identified as separate and distinct on the basis of breaks in the tracing of the displayed spectrograms. Series of individual calls were categorized as vocal bouts when the infant ceased vocalizing. Sometimes an infant would stop vocalizing and start vocalizing again after a brief period of silence. To determine what period of nonvocalization would indicate the end of a vocal bout we performed a survivorship analysis (SPSS for Windows, version 8.0, SPSS Inc., Chicago, IL; see Moya-Larano and Wise, 2000) on 125 randomly selected intercall intervals. This analysis indicated that 12.8% of the sampled intercall intervals were greater than 5 s, and less than 2% were separated by more than 15 s. We thus defined a 15-s interval separating two series of individual calls as a vocal bout. Two percent of the 2019 vocal bouts were determined using this 15-s interval definition. For each SRV bout, two scorers (MT and JD) first tallied the number of vocalizations belonging to each vocal type (see Table 2 ). Calls were classified according to spectrograms and descriptions of acoustic properties provided in previous studies (Gouzoules, Gouzoules, and Marler, 1984; Hauser, 1991; Lindburg, 1971; Newman, 1995; Rowell and Hinde, 1962) . Call duration, call rate, and the number of different types of vocalizations were also noted. Initially, both observers analyzed bouts together, and results were compared. After a sufficient period of training, observers analyzed bouts separately. Bouts, then, were subsequently checked at random by the primary scorer (MT) once per week, and interobserver reliability was determined to exceed 98%.
A total of 2018 SRV bouts from 74 different rhesus macaque infants were included in the analysis. Four hundred sixty-five of these SRV bouts were from 26 different control infants. Control subjects did not contribute equally to the data pool thus bouts by individuals with large contributions were randomly selected and excluded, until a 2 analysis indicated that individual contributions to the data did not differ across subjects. Sex differences in, and prenatal treatment effects on, infant behavior and mother responsiveness to SRVs were analyzed using Mann-Whitney U tests (MWU, SPSS for Windows, version 8.0, SPSS Inc.). Unmanipulated and vehicle control animals were Newman (1995) . b Rowell and Hinde (1962) . c Lindburg (1971) . d Gouzoules et al. (1984) .
compared on all dependent measures using a MANOVA (SPSS for Windows, version 8.0, SPSS Inc.). Univariate ANOVAS were used to compare sex differences for each of the bout characteristics. An assessment of treatment differences in vocal behavior was conducted using an ANOVA, with LSD posthoc analyses.
RESULTS
Sex Differences in Infant Vocal Behavior during SRVs
DMSO and unmanipulated control animals did not differ from one another when all dependent measures were compared using a MANOVA (females, MANOVA, Wilk's Lamda, F(7, 219) Ͻ1; males, MANOVA, Wilk's Lamda, F(7, 228) ϭ 1.36, P Ͼ 0.05) and were therefore combined by sex for the purposes of analysis. Overall, SRV bouts averaged 17.5 s in duration (SE ϭ 1.26) and included an average of 14.8 calls (SE ϭ 1.12). As seen in Fig. 1 , each of the infants used all nine call types during the first 8 months of life in SRV contexts. Table 3 presents comparisons between males and females. The percentage of each call type per bout employed by males and females differed across bout features (MANOVA, Wilks' Lambda, F(9,453) ϭ 3.46, P Ͻ 0.001). Overall, female bouts contained significantly more calls than did male bouts. Both male and female infants used coos and geckers more than any other call type. However, females used a significantly higher percentage of coos per bout than did males. Males, in contrast, used a significantly higher percentage of geckers than did females. Males and females used girneys infrequently, and girney usage did not differ between the sexes.
Of the six scream classes, males and females were both most likely to use noisy screams during SRV bouts, although males used a significantly higher percentage of noisy screams than did females. Males and females, on average, employed a comparable percentage of tonal screams, undulated screams, pulsed screams, and mixed screams. Females, on average, employed a significantly higher percentage of arched screams during SRV bouts than did male infants. Table 4 summarizes the direction and magnitude of the seven sex differences observed in SRV bouts. Five of these features (coo usage, arched scream usage, total number of calls, types of vocalizations, and SRV duration) were greater in females than in males. In contrast, gecker usage and noisy scream usage were higher in males than in females. Effect sizes of the sex differences were large, ranging from 0.88 for noisy scream usage to Ϫ1.63 for SRV duration, with three measures, coo usage, SRV duration, and average number of call types used in SRVs, having very large effect sizes of greater than 1 standard deviation (Cohen, 1988) .
The Effects of Prenatal Hormones on Sex Differences in Vocal Usage
There was a significant overall effect for males and females and treatment groups across all vocal features (MANOVA, Wilks' Lambda, F(12, 1995) ϭ 2.64, P Ͻ 0.001). Nine of the 13 vocal features varied by prenatal treatment and 6 of the 7 sexually differentiated SRV parameters differed significantly by treatment (Table  3) . Those vocal features that were not sexually differentiated were not further analyzed. In addition, noisy screams, which differed between males and females, did not vary with prenatal treatment and this category was therefore dropped from subsequent analyses. To assess the extent to which a prenatal treatment affected SRV characteristics, the 6 sexually differentiated vocal features were classified as "male-typical" if a feature differed significantly from normal females but did not differ from normal males and "female-typical" if a feature differed significantly from normal males, but did not differ from normal females. Vocal features were categorized as male-typical, female-typical, or not different from either sex for each treatment group. Table 5 summarizes the categorization of vocal features as female-typical or male-typical for the eight prenatal treatment groups.
Exogenous Prenatal Androgen Treatment of Females
Early exogenous androgen masculinized female SRVs. EAFs were male-typical on all six sexually dimorphic vocal features affected by prenatal treatment, differing from control females, but not from control males.
Prenatal androgen treatment late in gestation affected female SRVs less consistently. For three vocal features, geckers, duration, and types of vocalizations, LAFs were male-typical, but did not differ from either normal males or females in arched scream usage and 
Prenatal Blockade of Endogenous Androgen in Males
Flutamide treatment early in gestation had a mixed effect on male SRVs. EFMs displayed female-typical patterns of gecker and coo usage, while their usage of arched screams did not differ from either sex. EFMs displayed male-typical patterns of total number, duration, and types of vocalizations used during SRV bouts.
In contrast, late flutamide treatment in males had little effect on SRV behavior. LFMs were classified as female-typical for only one vocal feature, arched scream usage. In addition, LFMs did not differ from normal males and females in terms of coo and gecker usage. However, LFMs were indistinguishable from normal males on the other three vocal features.
Exogenous Prenatal Androgen in Males
Exogenous androgen in males had minimal effects on SRV behavior, regardless of the timing of treatment. For both early and late androgen treatments, males were indistinguishable from control males on five of the six vocal features. It is interesting to note, however, that LAMs displayed a female-typical pattern of coo usage, one of the most strongly sexually dimorphic vocal features observed.
Prenatal Blockade of Endogenous Androgen in Females
Surprisingly, prenatal flutamide treatment substantially affected the SRVs of females and in an unexpected direction. Late flutamide treatment of females produced male-typical patterns for five of the six vocal features, and the sixth feature (arched scream usage) was indistinguishable from both males and females. Thus, LFF SRVs were almost as completely masculinized as were those of EAFs. Early flutamide treatment had a less pronounced effect, with three of the six vocal features classified as male-typical, and one vocal feature indistinguishable from either normal males or females.
Sex Differences in Maternal Response to SRVs
Following an SRV bout, females and males contacted their mother at comparable percentages (between 42 and 45% for both sexes, MWU, Z ϭ Ϫ0.05, P Ͼ 0.05). Furthermore, males and females were equally likely to end SRVs without actively approaching the mother (55-58% of SRVs for each sex, MWU, Z ϭ Ϫ0.79, P Ͼ 0.05). In these latter cases, either the mother retrieved the infant or the infant simply stopped vocalizing. In contrast to infant behavior, maternal responsiveness to SRVs differed according to the sex of the infant. Mothers were more likely to respond to male infants (mean percentage of SRVs involving mother response ϭ 39%, SE ϭ 0.04) than to female infants (mean percentage of SRVs involving mother response ϭ 25%, SE ϭ 0.04, MWU, Z ϭ Ϫ2.22, P Ͻ 0.05). 
The Effects of Prenatal Hormones on Maternal Responsiveness
Maternal responsiveness to infant SRVs was affected by prenatal treatment of males, but not of females. Mothers of EFMs (mean ϭ 20%, SE ϭ 0.03), EAMs (mean ϭ 17%, SE ϭ 0.05), and LAMs (mean ϭ 20%, SE ϭ 0.04) were significantly less likely to retrieve their infants than were mothers of normal male infants (mean ϭ 39%, SE ϭ 0.04; EFMs vs males, MWU, Z ϭ Ϫ2.23, P Ͻ 0.05; EAMs vs males, MWU, Z ϭ Ϫ2.55, P Ͻ 0.05; LAMs vs males, MWU, Z ϭ Ϫ1.99, P Ͻ 0.05). Maternal responsiveness to the SRVs of these three male groups did not differ from that of normal females. LFMs (mean ϭ 28%, SE ϭ 0.08), on the other hand, were indistinguishable from normal males, and all female treatment groups were indistinguishable from normal females. Thus, early flutamide treatment, as well as early and late androgen treatment, in males produced maternal responsiveness to infant SRVs indistinguishable from that of normal females. Prenatal treatments had no identifiable effect on maternal response to the SRVs of female infants.
DISCUSSION
Sex Differences in SRVs
We found infant SRVs and maternal responsiveness to SRVs to be highly sexually differentiated during the first 8 months of life. As reported by Erwin and Mitchell (1973) , and unlike Kalin and Shelton (1998) , we found that females used more coos than did males. In addition to sex differences in coo usage, we found differences in the usage of other calls, as well as differences in bout duration and the number of types of vocalizations employed during separation-rejection contexts. These results support the notion that rhesus macaque vocalizations sexually differentiate very early in life during a period of intense mother-infant interaction.
Mothers were less responsive to the SRVs of female infants than those of male infants, similar to reports in children. For example, Malatesta and Haviland (1982) found that human mothers, after a period of separation, responded more to the facial expressions of boys than to those of girls, and the authors argued that this increased maternal responsiveness stemmed from a higher irritability in boys than in girls (Malatesta and Haviland, 1982) . Similarly, rhesus macaque mothers may be responding to differences in SRV characteristics between males and females.
Differences in female and male SRV characteristics are striking. Females emit lower intensity vocalizations sustained for longer periods, whereas males emit SRVs of shorter duration and of higher intensity. Males use more noisy screams than do females and this may affect the response of their mothers. Gouzoules et al. (1984) reported that mothers responded more vigorously to noisy screams than to four other scream types in a playback experiment. In addition, males also use more geckers than do their female counterparts, which are often accompanied by an intense convulsive jerking of the body and may therefore reflect a higher degree of emotionality than other calls and be more visually engaging (Lindburg, 1971) . Females use more coos and arched screams during SRV bouts than do males, which are tonal and of comparatively low intensity. Possibly the higher coo usage and more tonal nature of female SRVs make them less arousing to the mothers than are the SRVs of males.
Females had longer SRV bouts, on average, than did males. These longer female SRV bouts may reflect the lower response rates of mothers to female infant's SRVs, prolonging the SRV bout. Alternatively, since young females spend more time in proximity with their mothers (Lovejoy and Wallen, 1988) , separation from their mothers may be more distressing for female infants than it is for males. Thus, the differences between male and female vocal responses to maternal separation or rejection may reflect both characteristics of maternal behavior and differences in the social needs of the infants.
Females employ more types of vocalizations than do males, reflecting a greater complexity in female SRVs than in male SRVs. Malatesta and Haviland (1982) similarly found that girls employ a wider variety of facial expressions after periods of separation than do boys. The usage of more types of vocalizations or facial expressions could be an attention-getting strategy and supports Owren and Rendall's (1997) suggestion that variability in scream usage minimizes habituation, thus eliciting more attention from the mother. The lower response rates by mothers to infant female SRVs could encourage variability of infant female SRVs, in their attempts to elicit more maternal attention. However, variability in SRVs may not be as effective in eliciting a maternal response compared to the less complex, but higher intensity, SRVs of male infants.
The Effects of Prenatal Hormones on Sex Differences in Communication
We found substantial evidence that prenatal hormones affect sex differences in infant primate vocalizations. Early, but not late, androgen-treated females were consistently male-typical on all six sexually dimorphic vocal features. This almost complete masculinization of SRVs by early androgen treatment contrasts with more limited effects on other sexually dimorphic juvenile behaviors. For example, mounting, but not rough and tumble play, was masculinized by early androgen treatment of 25 days (Goy et al., 1988) . These differences in the effects of early androgen on SRVs, in contrast to rough play, may reflect our longer early treatment of 30 and 35 days. Alternatively, the effects support the notion offered by Goy et al. (1988) that different sexually dimorphic behaviors have different periods of maximal sensitivity. The testosterone dosage in the current study (20 mg/week) was much lower than dosages used by Goy et al. (1988) , producing no genital modification. That this low dosage had no detectable effects on genital differentiation (Herman et al., 2000) , but markedly affected vocal behavior, is a further demonstration that genital and behavioral differentiation have both different time courses and different sensitivities.
Late androgen treatments affected females less than did early treatments, although some masculinization of SRVs was still evident. Timing of androgen exposure, therefore, was an important determinant of the degree to which SRVs were modified. Some vocal parameters, such as geckers, SRV duration, and the types of vocalizations, appear to be affected by both early and late androgen exposure, whereas other vocal features are sensitive to androgen exposures only early in gestation. Goy and colleagues (1988) also noted that different behavioral end-points varied in terms of sensitivity to androgen exposure across gestation. We extend this concept to specific features of highly emotional infant vocalizations.
Prenatal flutamide treatment of males affected SRV behavior, but not to the extent that prenatal androgen affected female vocalizations. Early flutamide treatment resulted in male SRVs that were indistinguishable from females on three of six vocal measures. Although early flutamide treatments in males did not alter SRV behavior to the extent that early androgen treatment in females did, it provides some support for the notion that this is a period where androgens influence vocalizations. This is further supported by the finding that late flutamide treatments in males had an even smaller effect on SRVs, producing a female-typical alteration in only one call feature.
This study produced four groups of subjects with atypical prenatal androgen exposure, for which we expected not to find treatment effects. In accord with this view, males exposed to exogenous prenatal androgen, either early or late in gestation, displayed essentially male-typical SRVs. In contrast, flutamide treatment in females produced particularly surprising results. Early flutamide treatment of females produced male-typical patterns on three vocal features, while flutamide treatment late in gestation produced almost as extensive masculinization of SRVs as did early androgen treatment of females. Thus, the timing of exposure affected the degree of masculinization, but in a wholly unanticipated manner. Possibly, this effect reflects a direct action of the active flutamide metabolite hydroxyflutamide on placental or ovarian steroidogenic mechanisms or is a direct agonistic effect. This last possibility seems unlikely given the minimal effects that late androgen treatment had on female SRVs. Another possibility is that the effect of flutamide reflects its capacity to inhibit negative feedback (Veldhuis, Urban, and Dufau, 1992) , resulting in increased placental or ovarian estrogen secretion, raising the possibility that estrogens can masculinize SRVs. If true, our results would suggest this estrogenic action differs from the actions of androgens early in gestation.
Prenatal treatment effects on maternal responsiveness do not parallel treatment effects on vocal features. If mothers are responding to a particular vocal characteristic or set of characteristics, we would expect mothers of EAFs and LFFs, given the degree of SRV masculinization in these treatment groups, to respond to their infants at rates comparable to those of normal males. However, maternal response rates remained low. Mothers responded to all females, regardless of treatment group, at the same, and comparatively low, rates. Similarly, mothers responded to EFMs, EAMs, and LAMs as if they were females, even though their SRVs were not significantly female-typical. Possibly, mothers respond to very specific call features as early flutamide-treated males and LAMs both showed a female-typical pattern of coo usage, and their calls were responded to as if they were females. However, EAMs did not have increased coo usage and their mothers responded to their SRVs as did mothers of females. Thus, mothers may be responding to a combination of nonvocal gender cues and specific vocal features or they may be responding to SRV characteristics that we did not measure.
Vocal behavior, like other behaviors, is sexually dimorphic in infant rhesus macaques during the first 8 months of life, and these sex differences appear to be affected by the timing and character of prenatal hormonal exposure. Androgens administered to females early, but not late, in gestation significantly affected SRVs of females, whereas flutamide administered early and late in gestation caused males to be somewhat "female-like." The magnitude of the effects of prenatal treatments varied with the timing of exposure, supporting the notion that the sensitivity of different behavioral end-points varies significantly across gestation. Further research should concentrate on how these sex differences change as infants mature and whether or not infant female vocal behavior reflects a greater vocal flexibility or whether these differences might also reflect differences in early emotionality.
